Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
MWN-101 is an Fc-fusion protein in Phase 2 since March 2024 - notably, MWN-101's Fc architecture suggests a longer half-life than a standard fatty-acid-conjugated peptide, which would support less-frequent-than-weekly dosing
Efficacy and Safety of Exenatide Once Weekly Versus Sitagliptin or Pioglitazone as an Adjunct to Metformin for Treatment of Type 2 Diabetes (DURATION-2): A Randomised Trial
For medical benefits, physician-administered compounded drugs may be billed using miscellaneous drug coding
The Kosmotropic (Structure-Forming) Effect of Compensatory Solutes, 1997
US$ 26.20
US$ 24.14
US$ 27.17
